Walgreens Boots Alliance Agrees to Pay $2.8 Million to Settle Medicaid Overcharging Allegations

MT Newswires Live03-27

Walgreens Boots Alliance (WBA) agreed to pay over $2.8 million to settle allegations that it violated federal, Massachusetts and Georgia laws by submitting inflated prices for certain generic medications to the states' Medicaid programs, the US Attorney's Office for the District of Massachusetts said Thursday.

Walgreens' pharmacies allegedly submitted a higher "usual and customary price" to the MassHealth and Georgia Medicaid programs for certain generic medicines between 2008 and 2023.

The settlement resolves, in part, allegations brought by a whistleblower, according to the press release.

Walgreens did not immediately respond to MT Newswires' request for comment.

Price: 11.16, Change: +0.05, Percent Change: +0.50

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment